In a personal essay for MedPage Today, Brendan Harley, a professor and cancer survivor, argues that recent NIH funding cuts and a proposed transfer of hundreds of millions of dollars to the Department of Defense would jeopardize future medical breakthroughs. Harley says his own bone marrow transplant in 1995 was made possible by NIH-supported research that began in the 1950s as an exploratory project on radiation response. He warns that the current trajectory is "emptying the pipeline of cures."
Harley details the damage he says is already underway: from 2025 to 2026, the NIH reduced the number of new research grants it funded by almost 25%, and the Trump administration has repeatedly attempted to politicize grant decisions. He describes how one of his own R01 grants, studying endometriosis, was frozen, forcing him to stop paying graduate students and halt experiments. The grant was eventually restarted, but only after he removed the phrase "menstruating people" from the project description. He also cites polling showing close to a 50% drop in young scientists who see a future in academic research.
The author acknowledges that targeted investments in translational work are valuable, pointing to agencies like BARDA and ARPA-H, but insists that basic NIH-funded research underpins even rapid successes like the COVID-19 mRNA vaccines. Rather than cutting the NIH budget, he advocates doubling it, citing a 250% return on investment, and prioritizing collaborative, exploratory science. The essay is an opinion piece, and no contrary sources were included in the input.